Donnerstag, 27. Oktober 2016

  • Pressemitteilung BoxID 154950

Appellate court upholds Fresenius SE annual general meeting resolutions on authorized capital

binding decision confirms final legal validity

(lifePR) (Bad Homburg, ) The resolutions on authorized capitals adopted by a large majority at Fresenius SE's annual general meeting on May 8, 2009, are final and binding. This results from the decision delivered today by the appellate court (Oberlandesgericht) in Frankfurt am Main, Germany, with regard to a judicial clearance proceeding (Freigabeverfahren) initiated by Fresenius. An appeal to a higher court is not available. As a consequence, the authorized capitals, which are already recorded in the commercial register, are definitively available.

The judicial clearance proceeding was prompted by legal challenges filed by two individual shareholders. The court's presiding division (Senat) upheld Fresenius SE's argument that the company's interest in implementing the resolutions outweighs the plaintiffs' interest in staying such implementation. The legal challenge underlying the decision is pending with the same court. However, this forthcoming decision has now become irrelevant with respect to the authorized capital resolutions covered by the clearance proceeding.

Authorized capital is commonly used by companies to maintain financial flexibility. Fresenius has currently no plans for a capital increase.

This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g., changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.

Über Fresenius AG (SE)

Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care. In 2009, group sales were approximately €14.2 billion. On Dec. 31, 2009, the Fresenius Group had 130,510 employees worldwide.

For current information, visit the company's website at

Diese Pressemitteilungen könnten Sie auch interessieren

7x7 stellt nachhaltige Investments vor

, Finanzen & Versicherungen, 7×7 Unternehmensgruppe c/o 7x7sachwerte GmbH & Co. KG

Die Bonner 7x7finanz GmbH präsentiert sich am 12. November 2016 in Freiburg auf der Messe Grünes Geld. Dort können sich interessierte Anleger...

Altbau vor Kauf eingehend besichtigen

, Finanzen & Versicherungen, Wüstenrot & Württembergische AG

Vor dem Kauf eines älteren Hauses sollte man sich eingehend über den Zustand und durchgeführte Sanierungsarbeiten informieren. Denn es ist üblich,...

Firmenjubiläum bei der BKK ProVita in Nürnberg

, Finanzen & Versicherungen, BKK ProVita

Am 21.10.2016 feierte Frau Doris Tobisch ihr 25-jähriges Firmenjubiläum bei der BKK ProVita in Nürnberg. Im Rahmen einer kleinen Feierstunde...